Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Loading Events

« All Events

  • This event has passed.

Toronto CLL Support Group

July 12, 2021 @ 7:00 pm - 9:00 pm

|Recurring Event (See all)

An event every 2 months that begins at 7:00 pm on day Second of the month, repeating until November 14, 2022

Toronto CLL Support Group

Take a break and read all about it

CLL Society Ed Forum On Demand: CLL Society and Huntsman 5th Annual Patient & Caregiver Educational Forum

In partnership with Huntsman Cancer Institute (HCI), CLL Society invites you to attend our virtual Ed Forum focused on chronic lymphocytic leukemia (CLL). Featured speakers will present the basics of CLL diagnosis, early management, clinical trials, treatment options, COVID-19 considerations for CLL patients, patient perspectives, and strategies to become an effective self-advocate.

ASH 2021: Dr. Nitin Jain on First-Line Triple Combination Therapy with Venetoclax, Obinutuzumab, and Atezolizumab for Chronic Lymphocytic Leukemia (CLL)

At the American Society of Hematology (ASH) 2021, Dr. Nicole Lamanna, Associate Clinical Professor of Medicine at Columbia University Medical Center, interviewed Dr. Nitin Jain, Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. They discussed early results from an ongoing study of a triple combination therapy with venetoclax, obinutuzumab, and atezolizumab, a PD-L1 checkpoint inhibitor.

Dr. Diamond on Building a Better COVID-19 Vaccine for the Immunocompromised

Don Diamond. Ph.D., has been working for decades at City of Hope, Duarte, CA, constructing a new vaccine platform that will benefit the immunocompromised. It’s already been successfully used in post allogeneic hematopoietic stem cell (bone marrow) transplants to prevent a different viral infection, CMV.

New England Journal of Medicine February 24, 2022: Mechanism of Resistance to Noncovalent Bruton’s Tyrosine Kinase Inhibitors (BTKi)

In this study published in the New England Journal of Medicine in February 2022, a large group of researchers performed genetic testing in patients before treatment and in patients that relapsed or failed treatment with the noncovalent BTKi,  Pirtobrutinib. These tests allowed the researchers to discover many other genetic mutations in CLL/SLL cells. 

Ask Me Anything – Featuring Dr. Brian Koffman and Michele Nadeem-Baker

Dr. Brian Koffman participates in CLL Society’s new Facebook Live event to answer your questions on anything. With no prepared presentation as a part of this event, it is truly a time dedicated to get answers on COVID-19 precautions for the immunocompromised, his treatment journey, the building of CLL Society, and more.

Do You Want To Boost Your Business?

drop us a line and keep in touch


July 12, 2021
7:00 pm - 9:00 pm


Toronto CLL Society Support Group
105 Wellness Way
Toronto, Ontario M3N 0B1 Canada
+ Google Map